Most recently, the Breakthrough T1D-funded ADJUST-T1D clinical trial showed that, in people with T1D and obesity or overweight using an automated insulin delivery system, Ozempic can help manage both weight and blood sugar
This often includes: Review how you responded to semaglutide to choose an appropriate starting dose for the new medication Following the new medications titration schedule , which may begin slowly to reduce side effects Talking through what to expect in the first few weeks , especially with changes in appetite or digestion Scheduling a follow-up visit to confirm the new dose is working well and make any needed adjustments Learn more about how Ozempic compares to other medications: If you are using Ozempic for diabetes management For those using Ozempic to manage type 2 diabetes, stopping suddenly can lead to elevated blood sugar
As a glucagon-like peptide-1 (GLP-1) receptor agonist, Trulicity does not create physical dependence, and abrupt discontinuation will not trigger acute medical complications
Semaglutide is also the basis of Ozempic's sister drug, Wegovy, which has been approved by the Food and Drug Administration for chronic weight management
